Advertisement

The Role of Thrombin in Angiogenesis

  • Michael E. Maragoudakis
Part of the NATO ASI Series book series (NSSA, volume 294)

Abstract

Angiogenesis describes collectively a complex of cascade of events leading to the formation of new blood vessels. The process involves endothelial cell activation proliferation and migration, cell rearrangement or programmed cell death as well as production, degradation and realignment of the extracellular matrix.

Keywords

Angiogenic Action Endothelial Cell Activation Thrombin Receptor Matrigel Plug Thrombin Receptor Activate Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bartha, K., C. Brisson, G. Archipoff, C. de la Salle, F. Lanza, J.P. Cazenave, and A. Beretz. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J. Biol. Chem., 268:421429, 1993.Google Scholar
  2. Carney, D.H. Postclotting cellular effects of thrombin mediated by interaction with high-affinity thrombin receptors. In: Thrombin Structure and Function, Berliner J.L. ed., Plenum Press, pp. 351-396, 1992.Google Scholar
  3. DeMichele, M.A.A., D.G. Moon, J.W. Fenton, and F.L. Minnear. Thrombin’s enzymatic activity increases permeability of endothelial cell monolayers. J. Appl. Physiol., 69:1599–1606, 1990.PubMedGoogle Scholar
  4. Dichek, D. and T. Quertermous. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood, 74:222–228, 1989.PubMedGoogle Scholar
  5. Fenton, J.W. Regulation of thrombin generation and functions. Semin. Thromb. Hemost., 14:234–240, 1988.PubMedCrossRefGoogle Scholar
  6. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43:172–203, 1985.Google Scholar
  7. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1:27–31, 1995.PubMedCrossRefGoogle Scholar
  8. Galdal, J.G.N. Molecular mechanisms of thrombin-induced human and bovine endothelial cell activation. J. Lab. Clin. Med., 120:513–519, 1992.Google Scholar
  9. Garcia, J.G.N. Molecular mechanisms of thrombin-induced human and bovine endothelial cell activation. J. Lab. Clin. Med., 120:513–519, 1992.PubMedGoogle Scholar
  10. Garcia, J.G.N., C. Patterson, C. Bahler, J. Aschner, C.M. Hart, and D. English. Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J. Cell Physiol., 156:541–549, 1993.PubMedCrossRefGoogle Scholar
  11. Grant, D.S., K.I. Tashiro, B. Segui-Real, Y. Yamada, G.R. Martin, and H.K. Kleinman. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vivo. Cell, 58:933–943, 1989.PubMedCrossRefGoogle Scholar
  12. Haralabopoulos, G.C., D.S. Grant, H.K. Kleinman, P.I. Lelkes, S.P. Papaioannou, and M.E. Maragoudakis. Inhibitors of basement membrane collagen biosynthesis prevent endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Lab. Invest., 71(4):575–581, 1994.PubMedGoogle Scholar
  13. Haralabopoulos G.C., D.S. Grant, H.K. Kleinman, and M.E. Maragoudakis. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am. J. Physiol., (submitted for publication).Google Scholar
  14. Harris-Hooker, S.A., C.M. Gajdusec, T.N. Wight, and S.M. Schwartz. Neovascular response induced in cultured aortic endothelial cells. J. Cell Physiol., 114:302–310, 1983.PubMedCrossRefGoogle Scholar
  15. Jaffe, E.A., J. Grulich, B.B. Weksler, G. Hample, and Watanabe. Correlation between thrombin induced prostacyclin production and inositol triphosphate and cytosolic free calcium levels in human cultured endothelial cells. J. Biol. Chem., 262:8557–8565, 1987.PubMedGoogle Scholar
  16. Maragoudakis, M.E., M. Sarmonika, and M. Panoutsacopoulou. Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue and Cell, 20(4):531–539, 1988.PubMedCrossRefGoogle Scholar
  17. Maragoudakis, M.E., G.C. Haralabopoulos, N.E. Tsopanoglou, and E. Pipili-Synetos. Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods. Microvascular Res., 50:215–222, 1995.CrossRefGoogle Scholar
  18. Maragoudakis, M.E., N.E. Tsopanoglou, E. Sakkoula, and E. Pipili-Synetos. On the mechanism of promotion of angiogenesis by thrombin. FASEB J., 9:A587. 1995.Google Scholar
  19. Pankonin, G., and F. Teuscher. Stimulation of endothelial cell migration by thrombin. Biomed. Biochem. Acta, 50:1073–1078, 1991.Google Scholar
  20. Passaniti, A., R.M. Taylor, R. Pili, Y. Guo, P.V. Lowrey, J.A. Haney, R.R. Daniel, D.S. Grawd, and G.R. Martin, G.R. A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane heparin, fibroblast growth factor. Lab. Invest., 67:519–528, 1992.PubMedGoogle Scholar
  21. Prescott, S.M., G.A. Zimmerman, and T.M. McIntyre. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. USA, 81:3534–3538, 1984.PubMedCrossRefGoogle Scholar
  22. Rides, F.R., and R.L. Edwards. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood, 64:14–31, 1983.Google Scholar
  23. Silverstein, R.L. and R.L. Nachman. Cancer and clotting — Trousseau’s warning. N. Engl. J. Med., 327:1163–1164, 1992.PubMedCrossRefGoogle Scholar
  24. Sloan, B.F., J. Rozhin, K. Johnson, H. Taylor, J.D. Crissman, and K.V. Honn. Cathepsin B: Association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA, 83:2483–2487, 1986.CrossRefGoogle Scholar
  25. Tapparelli, C., R. Metternich, C. Ehrhardt, and N.S. Cook. Synthetic low molecular weight thrombin inhibitors: molecular design and pharmacological prolife. TIPS, 14:366–376, 1993.PubMedGoogle Scholar
  26. Tapparelli, C., R. Metternich, and N.S. Cook. Structure and function of thrombin receptors. TIPS, 14:426428, 1993.Google Scholar
  27. Tsopanoglou, N.E., E. Pipili-Synetos, and M.E. Maragoudakis. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol., 264 (Cell Physiol. 33):C1302–1307, 1993.PubMedGoogle Scholar
  28. Tsopanoglou, N.E., E. Pipili-Synetos, and M.E. Maragoudakis. Protein kinase C involvement in the regulation of angiogenesis. J. Vasc. Res., 30:202–208, 1993.PubMedCrossRefGoogle Scholar
  29. Tsopanoglou, N.E., G.C. Haralabopoulos, and M.E. Maragoudakis. Opposing effects on modulation of angiogenesis by protein kinase C and cyclic AMP-mediated pathways. J. Vasc. Res., 31:195–204, 1994.PubMedCrossRefGoogle Scholar
  30. Zucker S., Conner C., DiMassmo, B.I., Ende, H., Drew, M., Seiki, M and Bahou, W.F. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem., 270:23730–23738, 1996.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Michael E. Maragoudakis
    • 1
  1. 1.Dept. of PharmacologyUniversity of Patras Medical SchoolPatrasGreece

Personalised recommendations